Cautionary Tale of Using Patents to Extend Protection of One Cholesterol-lowering Drug, Tricor

The Washington Post recently (20 April 2012) published an article titled, “Want to cut health care costs, start here.”  A small change in prescribing cholesterol-lowering drugs would save Americans $700 million a year. The story is heavily excerpted below, and has been the subject of many blog posts. Every year, Americans pay $700 million more […]

Read More